Strides Pharma Science Limited — Important, 25-11-2024: General Updates

OneSource Specialty Pharma Limited has successfully completed a fundraise of USD 95 million from prominent domestic and international investors, valuing the company at USD 1.65 billion. The fundraising, led by HBM Healthcare Investments, attracted participation from notable investors such as WhiteOak Capital, Param Capital, and SBI Life Insurance. A total of 6,277,909 fully paid-up equity shares were issued at INR 1,276 per share, generating total proceeds of INR 8,010 million. This successful fundraising positions OneSource firmly as India's pioneering specialty pharma CDMO and sets the stage for its anticipated listing and potential growth opportunities. Stakeholders can expect further updates regarding the Scheme of Arrangement and the listing process as developments unfold.